Gastrointestinal complaints and hepatotoxicity were the most frequent drug adverse events, and such a finding was found also by Lima et al., who demonstrated an increased gastrointestinal MTX-related toxicity associated with the presence of RFC1-80G allele in 233 Caucasian RA patients. This evidence concerns the gene RFC1 and rheumatoid arthritis.